Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1801571

Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Description:
Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData’s new report, “Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the Australia Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Sunovion, CareFusion Corporation, Baxter International Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
 
Contents:
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Drug Delivery Devices In Australia
3.1 Drug Delivery Devices, Market Segmentation
3.2 Drug Delivery Devices, Australia, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2010
3.4 Drug Delivery Devices Market, Australia, Category Contribution (%), 2010
3.5 Drug Delivery Devices, Australia, Category Volume (Units), 2003-2017
3.6 Drug Delivery Devices, Australia, Company Share (2009-2010)
4 Central Venous Catheters In Australia
4.1 Central Venous Catheters, Market Segmentation
4.2 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2010
4.3 Central Venous Catheters Market, Australia, Segment Contribution (%), 2010
4.4 Central Venous Catheters Overall Revenue (2003-2017)
4.5 Central Venous Catheters Overall Volume (2003-2017)
4.6 Central Venous Catheters Average Price (2003-2017)
4.7 Central Venous Catheters Distribution Share (2009-2010)
4.8 Central Venous Catheters, Australia, Company Share (2009-2010)
5 Infusion Systems In Australia
5.1 Infusion Systems, Market Segmentation
5.2 Infusion Systems Market, Australia, Revenue Mix ($m), 2010
5.3 Infusion Systems Market, Australia, Segment Contribution (%), 2010
5.4 Infusion Systems Overall Revenue (2003-2017)
5.4.1 Syringe Pumps Revenue (2003-2017)
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017)
5.5 Infusion Systems Overall Volume (2003-2017)
5.5.1 Syringe Pumps Volume (2003-2017)
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017)
5.6 Infusion Systems Average Price (2003-2017)
5.7 Infusion Systems Distribution Share (2009-2010)
5.8 Infusion Systems, Australia, Company Share (2009-2010)
6 Metered Dose Inhaler Devices In Australia
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
6.5 Metered Dose Inhaler Devices, Australia, Company Share (2009-2010)
7 Needle Free Injections In Australia
7.1 Needle Free Injections Overall Revenue (2003-2017)
7.2 Needle Free Injections Overall Volume (2003-2017)
7.3 Needle Free Injections Average Price (2003-2017)
7.4 Needle Free Injections Distribution Share (2009-2010)
7.5 Needle Free Injections, Australia, Company Share (2009-2010)
8 Overview of Key Companies in Australia Drug Delivery Devices Market
8.1 GlaxoSmithKline plc
8.1.1 Company Overview
8.1.2 Share in the Australia Drug Delivery Devices Market
8.2 AstraZeneca PLC
8.2.1 Company Overview
8.2.2 Share in the Australia Drug Delivery Devices Market
8.3 Boehringer Ingelheim GmbH
8.3.1 Company Overview
8.3.2 Share in the Australia Drug Delivery Devices Market
8.4 Sunovion
8.4.1 Share in the Australia Drug Delivery Devices Market
8.5 CareFusion Corporation
8.5.1 Company Overview
8.5.2 Share in the Australia Drug Delivery Devices Market
8.6 Baxter International Inc.
8.6.1 Company Overview
8.6.2 Share in the Australia Drug Delivery Devices Market
8.7 Fresenius Kabi AG
8.7.1 Company Overview
8.8 Hospira, Inc.
8.8.1 Company Overview
8.9 Terumo Corporation
8.9.1 Company Overview
8.10 Teleflex Incorporated
8.10.1 Company Overview
8.11 Medtronic, Inc.
8.11.1 Company Overview
8.12 Consort Medical plc
8.12.1 Company Overview
8.13 Smiths Medical
8.13.1 Company Overview
8.14 B. Braun Melsungen AG
8.14.1 Company Overview
8.15 JMS CO., LTD.
8.15.1 Company Overview
8.16 NIPRO CORPORATION
8.16.1 Company Overview
8.17 Edwards Lifesciences Corporation
8.17.1 Company Overview
8.18 INJEX - Equidyne Systems
8.18.1 Company Overview
8.19 Bioject Medical Technologies Inc.
8.19.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 Drug Delivery Devices
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer

1.1 List of Tables
Table 1: Drug Delivery Devices, Australia, Overall Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices Market, Australia, Category Contribution (%), 2010
Table 3: Drug Delivery Devices, Australia Cross-Category Analysis, 2003-2017
Table 4: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 2003-2010
Table 5: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 2010-2017
Table 6: Drug Delivery Devices, Australia, Category Volume (Units), 2003-2017
Table 7: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2003-2010
Table 8: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2010-2017
Table 9: Drug Delivery Devices, Australia, Company Share by Revenue ($m), 2009-2010
Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2010
Table 11: Central Venous Catheters, Australia, Revenue ($m) by Segment, Historic, 2003-2010
Table 12: Central Venous Catheters, Australia, Revenue ($m) by Segment, Forecast, 2010-2017
Table 13: Central Venous Catheters, Australia, Volume (Units) by Segment, Historic, 2003-2010
Table 14: Central Venous Catheters, Australia, Volume (Units) by Segment, Forecast, 2010-2017
Table 15: Central Venous Catheters, Australia, Average Price ($), Historic, 2003-2010
Table 16: Central Venous Catheters, Australia, Average Price ($), Forecast, 2010-2017
Table 17: Central Venous Catheters, Australia, Distribution Share by Revenue ($m), 2009-2010
Table 18: Central Venous Catheters, Australia, Company Share by Revenue ($m), 2009-2010
Table 19: Infusion Systems Market, Australia, Segment Contribution (%), 2010
Table 20: Infusion Systems, Australia, Revenue ($m) by Segment, Historic, 2003-2010
Table 21: Infusion Systems, Australia, Revenue ($m) by Segment, Forecast, 2010-2017
Table 22: Syringe Pumps, Australia, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 23: Syringe Pumps, Australia, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 24: Ambulatory Infusion Pumps, Australia, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 25: Ambulatory Infusion Pumps, Australia, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 26: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2003-2010
Table 27: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2010-2017
Table 28: Syringe Pumps, Australia, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 29: Syringe Pumps, Australia, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 30: Ambulatory Infusion Pumps, Australia, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 31: Ambulatory Infusion Pumps, Australia, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 32: Infusion Systems, Australia, Average Price ($), Historic, 2003-2010
Table 33: Infusion Systems, Australia, Average Price ($), Forecast, 2010-2017
Table 34: Infusion Systems, Australia, Distribution Share by Revenue ($m), 2009-2010
Table 35: Infusion Systems, Australia, Company Share by Revenue ($m), 2009-2010
Table 36: Metered Dose Inhaler Devices, Australia, Revenue ($m), Historic, 2003-2010
Table 37: Metered Dose Inhaler Devices, Australia, Revenue ($m), Forecast, 2010-2017
Table 38: Metered Dose Inhaler Devices, Australia, Volume (Units), Historic, 2003-2010
Table 39: Metered Dose Inhaler Devices, Australia, Volume (Units), Forecast, 2010-2017
Table 40: Metered Dose Inhaler Devices, Australia, Average Price ($), Historic, 2003-2010
Table 41: Metered Dose Inhaler Devices, Australia, Average Price ($), Forecast, 2010-2017
Table 42: Metered Dose Inhaler Devices, Australia, Distribution Share by Revenue ($m), 2009-2010
Table 43: Metered Dose Inhaler Devices, Australia, Company Share by Revenue ($m), 2009-2010
Table 44: Needle Free Injections, Australia, Revenue ($m), Historic, 2003-2010
Table 45: Needle Free Injections, Australia, Revenue ($m), Forecast, 2010-2017
Table 46: Needle Free Injections, Australia, Volume (Units), Historic, 2003-2010
Table 47: Needle Free Injections, Australia, Volume (Units), Forecast, 2010-2017
Table 48: Needle Free Injections, Australia, Average Price ($), Historic, 2003-2010
Table 49: Needle Free Injections, Australia, Average Price ($), Forecast, 2010-2017
Table 50: Needle Free Injections, Australia, Distribution Share by Revenue ($m), 2009-2010
Table 51: Needle Free Injections, Australia, Company Share by Revenue ($m), 2009-2010
Table 52: Drug Delivery Devices Market Pipeline Products
Table 53: USD to Local Currency, Australia, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation
Figure 2: Drug Delivery Devices, Australia, Overall Revenue ($m), 2003-2017
Figure 3: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2010
Figure 4: Drug Delivery Devices Market, Australia, Category Contribution (%), 2010
Figure 5: Drug Delivery Devices Market, Australia, Cross-Category Analysis, 2003-2017
Figure 6: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 2003-2010
Figure 7: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 2010-2017
Figure 8: Drug Delivery Devices, Australia, Category Volume (Units), 2003-2017
Figure 9: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2003-2010
Figure 10: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2010-2017
Figure 11: Drug Delivery Devices, Australia, Company Share (%), 2010
Figure 12: Central Venous Catheters, Market Segmentation
Figure 13: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2010
Figure 14: Central Venous Catheters Market, Australia, Segment Contribution (%), 2010
Figure 15: Central Venous Catheters, Australia, Revenue ($m) by Segment, Historic, 2003-2010
Figure 16: Central Venous Catheters, Australia, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 17: Central Venous Catheters, Australia, Volume (Units) by Segment, Historic, 2003-2010
Figure 18: Central Venous Catheters, Australia, Volume (Units) by Segment, Forecast, 2010-2017
Figure 19: Central Venous Catheters, Australia, Company Share (%), 2010
Figure 20: Infusion Systems, Market Segmentation
Figure 21: Infusion Systems Market, Australia, Revenue Mix ($m), 2010
Figure 22: Infusion Systems Market, Australia, Segment Contribution (%), 2010
Figure 23: Infusion Systems, Australia, Revenue ($m) by Segment, Historic, 2003-2010
Figure 24: Infusion Systems, Australia, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 25: Syringe Pumps, Australia, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 26: Syringe Pumps, Australia, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 27: Ambulatory Infusion Pumps, Australia, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 28: Ambulatory Infusion Pumps, Australia, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 29: Infusion Systems, Australia, Volume (Units) by Segment, Historic, 2003-2010
Figure 30: Infusion Systems, Australia, Volume (Units) by Segment, Forecast, 2010-2017
Figure 31: Syringe Pumps, Australia, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 32: Syringe Pumps, Australia, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 33: Ambulatory Infusion Pumps, Australia, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 34: Ambulatory Infusion Pumps, Australia, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 35: Infusion Systems, Australia, Company Share (%), 2010
Figure 36: Metered Dose Inhaler Devices, Australia, Revenue ($m), Historic, 2003-2010
Figure 37: Metered Dose Inhaler Devices, Australia, Revenue ($m), Forecast, 2010-2017
Figure 38: Metered Dose Inhaler Devices, Australia, Volume (Units), Historic, 2003-2010
Figure 39: Metered Dose Inhaler Devices, Australia, Volume (Units), Forecast, 2010-2017
Figure 40: Metered Dose Inhaler Devices, Australia, Company Share (%), 2010
Figure 41: Needle Free Injections, Australia, Revenue ($m), Historic, 2003-2010
Figure 42: Needle Free Injections, Australia, Revenue ($m), Forecast, 2010-2017
Figure 43: Needle Free Injections, Australia, Volume (Units), Historic, 2003-2010
Figure 44: Needle Free Injections, Australia, Volume (Units), Forecast, 2010-2017
Figure 45: Needle Free Injections, Australia, Company Share (%), 2010
Figure 46: GlaxoSmithKline plc, Company Share (%),Australia Drug Delivery Devices Market, 2010
Figure 47: AstraZeneca PLC, Company Share (%),Australia Drug Delivery Devices Market, 2010
Figure 48: Boehringer Ingelheim GmbH, Company Share (%),Australia Drug Delivery Devices Market, 2010
Figure 49: Sunovion, Company Share (%),Australia Drug Delivery Devices Market, 2010
Figure 50: CareFusion Corporation, Company Share (%),Australia Drug Delivery Devices Market, 2010
Figure 51: Baxter International Inc., Company Share (%),Australia Drug Delivery Devices Market, 2010
 
Companies Mentioned
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
Sunovion
CareFusion Corporation
Baxter International Inc.
Fresenius Kabi AG
Hospira, Inc.
Terumo Corporation
Teleflex Incorporated
Medtronic, Inc.
Consort Medical plc
Smiths Medical
B. Braun Melsungen AG
JMS CO., LTD.
NIPRO CORPORATION
Edwards Lifesciences Corporation
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1801571

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Oct 25th 2014
6:33:11 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Drug Delivery Devices Market Outlook in Australia to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Web Address

http://www.researchandmarkets.com/reports/1801571

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License USD 5,000
Electronic (PDF) - Enterprisewide USD 7,500
Electronic (PDF) - Single User USD 2,500

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Oct 25th 2014
6:33:11 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)